Our Recommendations
- Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic) (2022)
- Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022 (2022)
- Protocolo de Manejo Clínico para o Novo Coronavírus (2019-nCoV) (2020)
- Manuel de prévention et de traitement du COVID-19 (2020)
- Covid-19 AMBOSS (2020)
New Publications
- Therapeutics and COVID-19 (Living Guideline, 10 November 2023) (2023)
- Clinical management of COVID-19: Living guideline, 18 August 2023 (2023)
- Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023 (2023)
- Clinical management of COVID-19: living guideline, 13 January 2023 (2023)
- Manejo clínico de la COVID-19, 14 de septiembre de 2022 (2022)
Filter
220
Featured
Recommendations
67
Language
Document type
Guidelines
123
Fact sheets
42
Manuals
23
Studies & Reports
8
Online Courses
7
Infographics
6
Situation Updates
5
Training Material
2
Resource Platforms
2
Videos
2
Countries / Regions
Russia
30
Brazil
23
Latin America and the Carribbean
14
Germany
11
Mozambique
8
West and Central Africa
8
Middle East and North Africa
8
Angola
8
Eastern Europe and Central Asia
7
Guinea-Bissau
6
Spain
6
Global
5
Ecuador
5
Syria
4
Africa
4
South Africa
4
Yemen
4
France
3
East and Southern Africa
3
Eastern Europe
3
India
3
Portugal
2
Vietnam
2
Sudan
2
Switzerland
1
Ukraine
1
Turkey
1
Benin
1
Togo
1
Cameroon
1
Nigeria
1
Canada
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Burkina Faso
1
Burundi
1
Austria
1
Philippines
1
Italy
1
Haiti
1
Saudi Arabia
1
South–East Asia Region
1
Western Pacific Region
1
Western and Central Europe
1
Luxembourg
1
Belgium
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Djibouti
1
Mali
1
Chad
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
117
Clinical Guidelines
18
Women & Child Health
9
Capacity Building
4
Key Resources
1
Pharmacy & Technologies
1
Reseña normativa de la OMS:
16.7.2021
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
6a edición clínica. Nuevo: 4. Vacunas (26 de abril); Nuevo: 5. Pruebas y procedimientos de diagnóstico (7 de abril); Nuevo: 7. COVID-19 persistente (7 de abril)
Il nuovo mini-textbook
Nei prossimi mesi, COVID Reference presenterà aggiornamenti regolari e racconterà i dati scientifici nel modo più completo possibile.
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
The sixth course of the Clinical Management of Patients with COVID-19 course series is devoted to the rehabilitation of patients with COVID-19. The seven course modules address the manifold and varied rehabilitation needs of patients recovering from COVID-19, including patients with cognitive impair...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
Diagnostik zum Nachweis von COVID-19
recommended
Im Kapitel zu Diagnostik zum Nachweis von COVID-19 bekommen Sie ausführlich die verschiedenen Testmethoden erklärt, es können Videos zu PCR, RAchenabstrich, etc. aufgerufen werden
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la prévention et le traitement ...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Actualizadas en el documento titulado «Vigilancia de salud pública en relación con la COVID-19» publicado el 16 de diciembre de 2020
Обновление рекомендаций по санитарно-эпидемиологическому надзору за COVID-19 от
16 декабря 2020 г
Actualisées dans « La surveillance de la santé publique dans le contexte de la COVID-19 », publié le 16 décembre 2020
